Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

1.43
Delayed Data
As of Jan 13
 -0.02 / -1.38%
Today’s Change
1.16
Today|||52-Week Range
8.49
+13.49%
Year-to-Date

Today’s Trading

Previous close1.45
Today’s open1.44
Day’s range1.41 - 1.47
Volume7,171,320
Average volume (3 months)16,233,787
Market cap$387.9M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-62.16%
Earnings growth (this year)-74.64%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+18.24%
P/E ratioNM
Price/Sales60.70
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
BOLDAudentes Therapeutic...+0.18+1.02%
ONVOOrganovo Holdings In...+0.03+0.82%
NSTGNanoString Technolog...+0.18+0.96%
PDLIPDL BioPharma Inc-0.02-0.87%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 13, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$36.3M
Annual profit (last year)-$156.9M
Net profit margin-432.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts


Search for Jobs